Active tDCS + Cognitive Training for Mild TBI in Active Duty Service Members
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to treat mild traumatic brain injury (mTBI) using transcranial direct current stimulation (tDCS) combined with cognitive training. The researchers aim to determine if this combination can improve attention and memory issues in active duty service members with a history of mild TBI. Participants will receive either real or sham (inactive) tDCS to compare effects. The trial seeks active duty members who experienced mild TBI more than six months ago and face moderate attention or memory problems. As an unphased trial, this study offers a unique opportunity to contribute to pioneering research that could lead to new treatment options.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must be stable on any medications for at least 2 weeks before starting the trial.
What prior data suggests that this brain stimulation technique is safe for cognitive rehabilitation?
Studies have shown that transcranial direct current stimulation (tDCS) safely stimulates the brain. The FDA considers it low risk for individuals with neurological issues. Research on people with severe traumatic brain injury found that a single use of tDCS was safe. Although not yet approved for regular medical use, tDCS has been safely used in trials.
Cognitive training, another part of this trial, improves thinking and memory skills in people with mild traumatic brain injury (TBI). Reviews have found cognitive training to be safe and helpful, especially for those with mild to moderate TBI.
Overall, both tDCS and cognitive training are well-tolerated, with minimal risk of side effects.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they combine cognitive training with transcranial Direct Current Stimulation (tDCS) to target Mild Traumatic Brain Injury (TBI). Unlike traditional therapies that often focus on medication or physical therapy, tDCS uses a non-invasive electrical current to stimulate specific brain areas, potentially enhancing cognitive function and recovery. This method could offer a more direct way to improve working memory and cognitive performance, providing a novel approach to treating Mild TBI in active duty service members.
What evidence suggests that this trial's treatments could be effective for mild TBI?
Research shows that transcranial direct current stimulation (tDCS) may improve thinking and movement skills. Studies have found that tDCS can be particularly beneficial after a stroke by enhancing neuroplasticity, the brain's ability to change and heal itself. In individuals with consciousness disorders, tDCS has improved scores on cognitive tests. This trial will compare active tDCS with sham tDCS to evaluate its effectiveness in aiding recovery from mild traumatic brain injuries (mTBI). Although more research is needed, these findings suggest that tDCS might be useful for mTBI recovery.678910
Who Is on the Research Team?
Lars D Hungerford, PhD
Principal Investigator
United States Naval Medical Center, San Diego
Are You a Good Fit for This Trial?
Active Duty Service Members aged 18-55 with a history of mild TBI at least 6 months prior and moderate neurocognitive symptoms. Participants must be stable on medications for two weeks before starting the trial. Exclusions include a history of seizures, recent neuromodulation studies, intellectual disability, significant neurological disorders other than mild TBI, current stimulant dependence or active psychosis/manic episodes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial direct current stimulation (tDCS) combined with cognitive training over five consecutive days
Post-intervention Assessment
Participants undergo post-intervention assessment of symptoms, neurocognitive performance, and optional MRI scan
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of symptoms and neurocognitive performance
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Training Intervention
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Naval Medical Center, San Diego
Lead Sponsor
The Defense and Veterans Brain Injury Center
Collaborator